AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Oct 01 2021
Headline Roundup
Merck Says It Has First Effective Antiviral Pill To Treat COVID-19
American drugmaker Merck announced Friday that it will seek emergency authorization of an experimental antiviral pill known as molnupiravir after it significantly reduced the worst effects of COVID-19 in clinical trials. The company said that in the trials, the treatment cut the risk of hospitalization or death in half when given to high-risk patients within the first five days of COVID-19
Politico
Washington Times 
Associated Press
Oct 11 2021
Headline Roundup
Merck Asks FDA for Emergency Approval of Antiviral COVID-19 Pill
Pharmaceutical drugmaker Merck and its partner Ridgeback Biotherapeutics announced Monday that it has asked the Food and Drug Administration (FDA) for emergency approval of its COVID-19 pill. The company says the pill, called molnupiravir, reduced the risk of hospitalization or death in patients with mild to moderate COVID-19 by about 50% in a late-stage clinical trial. Researchers at Emory
STAT
New York Post (News)
USA TODAY
Nov 04 2021
Headline Roundup
UK Becomes First Country To Authorize Use Of Merck's COVID-19 Pill
Britain has become the first country in the world to authorize the use of Merck's antiviral pill to treat COVID-19. Sajid Javid, the UK's Secretary of State for Health and Social Care, said the drug will be "a game-changer for the most vulnerable and the immunosuppressed." The drug, known as molnupiravir, was approved based on clinical studies that showed the pill reduced the risk of
BBC News
The Epoch Times
Washington Post
Nov 16 2021
News
8 lingering questions about the new Covid pills from Merck and Pfizer
The past two months have brought extremely good news in the fight against Covid-19. Two different oral treatments have proved effective at both preventing people newly diagnosed with Covid-19 from entering the hospital and from dying.
“We’re accelerating our path out of this pandemic,” President Biden said after data on the second Covid pill became available. The wide availability of
STAT
Oct 17 2021
Data
Merck, Pfizer COVID-19 Antivirals Different From Ivermectin
Merck and Pfizer are each developing a new oral antiviral drug that might prevent or treat COVID-19. The pills are very different from the antiparasitic medication ivermectin, contrary to claims online that they are “suspiciously similar” or that the companies are “repackaging” ivermectin in a ploy to increase profits.
Throughout the COVID-19 pandemic, there has not been an easy-to-take
FactCheck.org
Oct 11 2021
News
Merck asks FDA for emergency approval of its antiviral COVID-19 pill
Pharmaceutical giant Merck and its partner Ridgeback Biotherapeutics announced Monday that it has asked the Food and Drug Administration for emergency approval of its COVID-19 pill after the experimental drug showed “compelling results” in clinical trials.
The pill, called molnupiravir, cut the risk of hospitalization or death in patients with mild to moderate COVID-19 by about 50
New York Post (News)
Oct 01 2021
News
Merck says experimental pill cuts worst effects of COVID-19
Drugmaker Merck said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus, potentially a leap forward in the global fight against the pandemic.
The company said it will soon ask health officials in the U.S. and around the world to authorize the pill’s use. A decision from the U.S. Food and Drug
Associated Press
Aug 14 2017
News
Merck CEO pulls out of Trump panel, demands rejection of bigotry
Merck's chief executive resigned on Monday from a business panel led by Donald Trump, citing a need for leadership countering bigotry in a strong rebuke to the U.S. president over his response to a violent white nationalist rally in Virginia.
Reuters
Aug 14 2017
News
Merck CEO resigns from presidential council over Trump remarks
An African-American CEO of a major pharmaceutical company has resigned from a presidential council in a direct response to President Trump's remarks about "many sides" being to blame for violence over the weekend in Charlottesville, Va.
The Hill
Dec 06 2021
News
Pfizer and Merck Covid-19 Pills Are Coming Soon in the U.S., but Other Countries Will Have to Wait
Promising Covid-19 treatment pills are likely to take longer to reach patients in low- and middle-income countries than in rich ones because of manufacturing and pricing obstacles, despite efforts by drugmakers to make them more available, drug-access advocates and public-health experts say.
The pills promise to keep people who get infected from developing severe disease that requires
Wall Street Journal (News)